Home > Products > CCR3 & CD300
> Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (scIgG)
Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (scIgG) (CAT#: SCIGG-028)
Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CCR3 and anti-CD300 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb canreduce eosinophil signaling, inhibit bronchoalveolar lavage fluid inflammation, eosinophil, mast cell mediator release and reverse lung inflammation. It is designed for the research of Asthma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (scIgG) (SCIGG-028). Click the button below to contact us or submit your feedback about this product.